257 related articles for article (PubMed ID: 30465360)
1. Comparison Of The Efficacy Of Sildenafil Alone Versus Sildenafil Plus Bosentan In Newborns With Persistent Pulmonary Hypertension.
Fatima N; Arshad S; Quddusi AI; Rehman A; Nadeem A; Iqbal I
J Ayub Med Coll Abbottabad; 2018; 30(3):333-336. PubMed ID: 30465360
[TBL] [Abstract][Full Text] [Related]
2. Persistent Pulmonary Hypertension of the Newborn: The Efficacy Comparison of Vasodilators Sildenafil Plus Bosentan Versus Sildenafil Plus Beraprost at a Tertiary Childcare Health Facility.
Adnan M; Arshad MS; Anwar-Ul-Haq HM; Ahmad M; Afsheen H; Raza H
Cureus; 2021 Nov; 13(11):e20020. PubMed ID: 34987908
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of oral sildenafil for neonates with persistent pulmonary hypertension of newborn (PPHN): a prospective study in a tertiary care hospital.
Kamran A; Rafiq N; Khalid A; Amin F; Kumari V; Shaikh AS; Tebha SS; Patel N
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6787-6793. PubMed ID: 33980104
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial.
El-Ghandour M; Hammad B; Ghanem M; Antonios MAM
Paediatr Drugs; 2020 Dec; 22(6):685-693. PubMed ID: 32856285
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil in Term and Premature Infants: A Systematic Review.
Perez KM; Laughon M
Clin Ther; 2015 Nov; 37(11):2598-2607.e1. PubMed ID: 26490498
[TBL] [Abstract][Full Text] [Related]
6. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
[TBL] [Abstract][Full Text] [Related]
7. Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension.
McLaughlin V; Channick RN; Ghofrani HA; Lemarié JC; Naeije R; Packer M; Souza R; Tapson VF; Tolson J; Al Hiti H; Meyer G; Hoeper MM
Eur Respir J; 2015 Aug; 46(2):405-13. PubMed ID: 26113687
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Vasodilator Therapy in Children with Single Ventricle Physiology: Effects on Saturation and Pulmonary Arterial Pressure.
Jeremiasen I; Tran-Lundmark K; Idris N; Tran PK; Moledina S
Pediatr Cardiol; 2020 Dec; 41(8):1651-1659. PubMed ID: 32734529
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary vasodilator therapies in pulmonary arterial hypertension associated with CHD: a systematic review and network meta-analysis.
Yasuhara J; Watanabe K; Watanabe A; Shirasu T; Matsuzaki Y; Watanabe H; Takagi H; Sumitomo N; Kuno T
Cardiol Young; 2023 Nov; 33(11):2297-2311. PubMed ID: 36721907
[TBL] [Abstract][Full Text] [Related]
10. Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn.
Kahveci H; Yilmaz O; Avsar UZ; Ciftel M; Kilic O; Laloglu F; Ozturk K
Pediatr Pulmonol; 2014 Dec; 49(12):1205-13. PubMed ID: 24420987
[TBL] [Abstract][Full Text] [Related]
11. Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
Imam SS; El-Farrash RA; Taha AS; Saleh GA
J Cardiovasc Pharmacol; 2022 Nov; 80(5):746-752. PubMed ID: 35881893
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil for pulmonary hypertension in neonates.
Shah PS; Ohlsson A
Cochrane Database Syst Rev; 2007 Jul; (3):CD005494. PubMed ID: 17636802
[TBL] [Abstract][Full Text] [Related]
14. Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights.
Dardi F; Manes A; Palazzini M; Bachetti C; Mazzanti G; Rinaldi A; Albini A; Gotti E; Monti E; Bacchi Reggiani ML; Galiè N
Eur Respir J; 2015 Aug; 46(2):414-21. PubMed ID: 26022952
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.
Vizza CD; Jansa P; Teal S; Dombi T; Zhou D
BMC Cardiovasc Disord; 2017 Sep; 17(1):239. PubMed ID: 28874133
[TBL] [Abstract][Full Text] [Related]
16. Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study.
Al Omar S; Salama H; Al Hail M; Al Rifai H; Bunahia M; El Kasem W; Siddiqui FJ; Dilawar M; Yassin H; Masud F; Mohamed A; Mansour A
J Neonatal Perinatal Med; 2016 Sep; 9(3):251-9. PubMed ID: 27589542
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension.
Vizza CD; Sastry BK; Safdar Z; Harnisch L; Gao X; Zhang M; Lamba M; Jing ZC
BMC Pulm Med; 2017 Feb; 17(1):44. PubMed ID: 28228114
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States.
Angalakuditi M; Edgell E; Beardsworth A; Buysman E; Bancroft T
J Med Econ; 2010; 13(3):393-402. PubMed ID: 20608882
[TBL] [Abstract][Full Text] [Related]
19. Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health.
Khorana M; Yookaseam T; Layangool T; Kanjanapattanakul W; Paradeevisut H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S64-73. PubMed ID: 22043756
[TBL] [Abstract][Full Text] [Related]
20. Cost Effectiveness of Bosentan for Pulmonary Arterial Hypertension: A Systematic Review.
You R; Qian X; Tang W; Xie T; Zeng F; Chen J; Zhang Y; Liu J
Can Respir J; 2018; 2018():1015239. PubMed ID: 30581511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
